Showing 2571-2580 of 4067 results for "".
- Analysis Forecasts 140% Rise in Basal Cell Carcinoma Incidence by 2050https://reachmd.com/news/analysis-forecasts-140-rise-in-basal-cell-carcinoma-incidence-by-2050/2485719/An analysis projected that incident basal cell carcinoma (BCC) among adults aged 65 ye
- Multiomic Blood Signatures Forecast Trauma Outcomes: CU Anschutz Reporthttps://reachmd.com/news/multiomic-blood-signatures-trauma-outcomes/2485672/Investigators at the University of Colorado Anschutz are using longitudinal plasma multiomic pro
- Nutrafol Launches Men 50+ Formula Targeting Age-Related Hair Thinninghttps://reachmd.com/news/nutrafol-launches-men-50-formula-targeting-age-related-hair-thinning/2485568/Nutrafol announced an expansion of its men’s portfolio with the launch of Nutrafol Men 50+, a product designed specifically for men aged 50 years and older with thinning hair. According to the company, men entering their 50s ex
- Revolutionizing Newborn Screening: A Leap Forward in Cystic Fibrosis Detectionhttps://reachmd.com/news/revolutionizing-newborn-screening-a-leap-forward-in-cystic-fibrosis-detection/2485559/Newborn screening guidelines now expand and standardi
- AI-Supported Mammography Screening: A Leap Forward in Oncologyhttps://reachmd.com/news/ai-supported-mammography-screening-a-leap-forward-in-oncology/2485529/The MASAI randomized screening trial observed a descriptively lower proportion of interval breast cancers with unfavorable cha
- Strategic Shifts in Orthopedic Device Commercialization: Forma Medical's Focus on OptimalMTP™https://reachmd.com/news/strategic-shifts-in-orthopedic-device-commercialization-forma-medicals-focus-on-optimalmtptm/2485526/In a strategic move aimed at redefining the landscape of foot and ankle surgery,
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://reachmd.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Innovative Blood Biomarker Panel: A Step Forward in Pancreatic Cancer Detectionhttps://reachmd.com/news/innovative-blood-biomarker-panel-a-step-forward-in-pancreatic-cancer-detection/2485485/A new four-biomarker panel
- FDA Priority Review for Vyvgart in Seronegative MGhttps://reachmd.com/news/fda-priority-review-vyvgart-seronegative-mg/2485305/The FDA has accepted a supplemental Biologics License Application for Vyvgart (efgartigimod alfa-fcab), seeking an expanded indication for adults with AChR-Ab seronegative general
- Orelabrutinib: A Leap Forward in SLE Therapy from Phase IIb to Phase IIIhttps://reachmd.com/news/orelabrutinib-a-leap-forward-in-sle-therapy-from-phase-iib-to-phase-iii/2485087/Orelabrutinib met its primary endpoint in a Phase IIb study